Basically these anabolic steroids should be used with the help of doctor who must prescribe with required steroids. When we buy steroids every care should be taken to avoid side affects. Some of the side affects that infect are typical hair loss which leads to ultimate baldness. You can experience severe acne problem also. There are other common side affects they are inclined blood pressure and inclined cholesterol levels. These drugs largely benefited in the therapy of testosterone for HIV affected people.

Ever since the popularity of Olympic Games many sport personalities started using these drugs in order to ameliorate their performance. When we buy steroids these drugs assist to build up efficacious muscle strength which ultimately hastes the process of body building in a facile manner. It is also used in the medical field where it is subjected to ill health patients for curing their ailments. It is more common in treating AIDS patients all around the globe.

When we buy steroids it is mostly recommended to take required steroid dosage according to doctor’s prescription. Some times the over dosage leads to acute menaces. It leads to mal function in the liver regions where one can subject to be infected with cancer in liver. They should be carefully guided by the physicians with regard to dosage and quantity of intake of the drugs.

Demerits and risk factor

Normally when we buy steroids you can find some of the side affects among the customer’s around the globe. Apart from baldness, high BP, high Cholesterol, acne menaces and liver cancer you can also come across depression. There are chances in breast enlargement for men and male characteristics among women.

Where to purchase the steroids

In earlier days there was lot more restrictions implied on the sale of steroids for global users. But now in present modern world of scientific development any one can buy the steroids with out any fear. Lot more steroids were sold over net where you can order from your bedroom itself. It is better always to follow the doctor prescription and then purchase the anabolic steroids from reputed firms in order to avoid the bamboozler people.

It is also possible that while eating brown rice instead of white rice cuts down the risk of developing diabetes almost by 33%. In general White rice has a higher glycemic index (GI). After eating white rice there is a sudden increase in the post-prandial blood sugar evel  (BSL). This is one of the triggering factors for the development of type-2 diabetes. Eating brown rice had exactly opposite effects. A diet that is high in brown rice helps prevent the onset on type-2 diabetes.

But if you think about this in a different manner then you will think that this might not be wholly true. Rice comprises only 2% of American diet, while in some Asian diets it constitutes about 30% of their diet. It is trusted that there is higher prevalence of diabetes among the American population than the Asians.

Many people who eat brown rice may also be following other diet regulations like including whole grains, fresh fruits and vegetables in their diet. They might also be exercising regularly. With potent statistical evidence it is trusted that the American research gives to believe that eating white rice causes diabetes. Although brown rice is good for health, white rice is not all that bad either. It is low in sodium, fat content and goes well with cooked vegetables. It is important to consume or eat it in moderation.

Eventually it is said that White rice increases the risk of developing diabetes and also would be more appropriate to say that Brown rice reduces the risk of developing diabetes.

The latest trend in the pharmaceutical business is the tie-ups between Multi National Companies and Indian Pharmaceutical companies. These MNCs turn to their Indian counterparts to achieve cost-efficiency in terms of R & D. Besides offering skill and technology, offer affordable Research and Development facilities. For example, mergers and acquisitions between MNCs and Indian pharmaceutical companies are common for research on third world diseases like cancer, AIDS, etc.

Moreover, India is gradually moving up from being just a service provider to a value-add in profits. Here, MNCs purchase / license new products or share Intellectual Property. Pharmaceutical companies of India are slowly becoming a popular destination for collaborative research and development.

Adding to this is the success of the Indian pharmaceutical industry as an exporter of high quality generic drugs. The companies owe this success to the system of product patents which were introduced on 1stJanuary, 2005. Now, the Indian pharmaceutical industry exports drugs to approximately 65 countries around the world with the United States as its biggest market. The industry’s export was worth US 3.75 billion dollars and growing at a compound annual rate of 22.7% according to the National Pharmaceuticals Policy for 2006.

However, the these companies can hope to achieve more by discovering untapped markets both in India as well as abroad. Another area that calls for attention is the Research & Development department. The government needs to invest more for Research & Development as innovative drugs are high on demand.

Also, the relationship between pharmaceuticals and biotechnology in India needs to be more cemented. This is because biotechnology has a lot of room for growth with the rise in vaccines and bio – services. Lacks of funding and skilled employees are the obstacles for the development of biotechnology in Indian pharmaceutical companies. However, a wind of change is expected as the drugs go off patent, giving the Indian pharmaceutical companies an opportunity to upgrade their manufacturing capabilities.

To conclude, the companies have a lot of potential in store. It is estimated that the Indian pharmaceutical industry will soon enter the top 10 list of the pharmaceutical industries in the world.

Pharmaceutical companies of India are growing its pharmaceutical business to keep the feet stuck in world pharma industry.
By Chris Shirley
Article Source: http://EzineArticles.com/?expert=Chris_Shirley
http://EzineArticles.com/?The-Rise-of-the-Indian-Pharmaceutical-Companies&id=4591988

Pharmaceutical consultants agree that leading companies are not being able to acquire all the people they need at the exact time they need them, thus, very big and important projects are being postponed; and even though the biotech industry is not very spirited right now, it still needs the skills that are out there in the shape of a large number of engineering professionals, mastering and doctoring in pharmaceutical engineering and who are filling top positions in these leading companies. A great many engineers are applying for these specialized jobs given how much easier globalization has made the process.

Normally, pharmaceutical engineering graduates prefer to center on cross-functional skills instead of focusing on merely fundamental science; this is why, they begin at a small company and later move to bigger ones when they have more scientific, and pharmaceutical business experience. Along the way, some meaningful training programs may have enhanced engineers’ careers, but consistency in these is not the rule.

Currently, India and China are graduating large numbers of these specialized engineers, who are fairly competing against US graduates for big positions amoung the most powerful company brands. A big plus has been the lower restriction that the US has put upon the H-1B visas, making it easier for Indian and Chinese professionals to apply for interesting positions. In the long run, the growing number and quality of these graduates is being encouraged in order to meet the rising demand expected of the industry.

If you enjoyed this article about a Pharmaceutical consultants, please feel free to post it to your site or blog and forward this link to your friends. Have a great day!

Don’t forget to visit our blog.

Pharmaceutical consultants – http://www.smartconsultinggroup.com/

By Nigel Smart

Article Source: http://EzineArticles.com/?expert=Nigel_Smart

http://EzineArticles.com/?The-Future-of-Engineering-in-Pharmaceuticals&id=2786913

Earlier in India, these medicines were provided by various multinational companies. However, this monopoly ended with the Indian pharmaceutical industry taking a revolutionary turn in the 1970s with the enactment of the Indian Patent Act that allowed local development of pharmaceutical industry.

At present, the Indian pharmaceutical business has become the third largest in the world in terms of volume and fourteenth in terms of value. It is estimated to touch US $20 billion and enter the list of the top 10 global pharmaceutical markets. The future of the Indian pharmaceutical business development seems favourable due to the increase in demand for generic APIs and India has emerged as a frontrunner in the production of these generic Active Pharmaceutical Ingredients (APIs). Competency in technology and skillful workforce has contributed to the success of pharmaceutical business development. Also, affordable rates have played a pivotal role in the pharmaceutical business development. As a result, the Indian pharmaceutical sector is thriving at about CAGR of 13.7%.

Also, many Indian companies have made their mark on a global level as they have tied up with several MNCs for research & development of diseases like cancer, AIDS and other third world diseases. What adds to the Indian pharmaceutical business development is the outsourcing received from MNCs who look for a reduction in their manufacturing costs. The only downfall here is that MNCs are promoting ‘authorised generics’, which entangle the native pharmaceutical companies in expensive litigations.

The pharma business development program, therefore, aims at increasing distribution and discovering new international markets. For this, the pharmaceutical industry will need to engage in increasingly aggressive marketing strategies. To develop the pharmaceutical business, investment in research and development (R&D) for new products is a necessity.

Some of the other factors that call for attention for pharma business development are the infrastructure facilities in India that continue to hamper growth by frequent power-cuts and poor transportation facilities. The Indian pharmaceutical industry will need to exploit the advances made in Bio-technology and Information Technology. Finally, the cost factor needs to be controlled without letting it interfere with the launch of new products.

The Indian pharmaceutical business growth rate showed a 25% increase in the last year alone. Therefore, the Government of India has reduced payments to the research association in the 2010 budget. The Indian pharmaceutical business is yet to reach its maximum potential. However, it does not seem too far with effective measures taken in marketing, research and development.

Chris Reeve writes the articles on pharmaceutical companies, its business and pharma research and pharmaceutical development.

By Chris Reeve

Article Source: http://EzineArticles.com/?expert=Chris_Reeve

http://EzineArticles.com/?The-Future-and-Business-Development-of-the-Indian-Pharmaceutical-Industry&id=4204111

Evidence of this is the fact that India is predicted to enter the big league of the top 10 pharmaceutical markets in the world. Currently, India ranks 14th in terms of value and 3rd in terms of volume. It is obvious then, that the Indian pharmaceutical industry is a contributor to the country’s growth and development. As India offers a perfect combination of skills, technology and economy, many foreign companies have started outsourcing their manufacturing departments to India. Also, some Indian companies have joined hands with MNCs for research and development (R & D) in projects like cancer, AIDS, etc. India’s IT sector plays a pivotal role in enticing MNCs to outsource research and drug discovery contracts.

This road to success was led by the system of product patents introduced on 1st January, 2005. Due to this, India has become a worldwide exporter of high quality generic drugs. India exports to 65 countries with US as its biggest market. According to the National Pharmaceuticals Policy for 2006, the industry’s export was worth US 3.75 billion dollars and growing at a compound annual rate of 22.7%.

In spite of this success story, the Indian pharmaceutical business has room for improvement. To utilise their capacity to the fullest, the India pharmaceutical industry is seeking untapped global as well as local markets. In India, one of the goals of the Indian pharmaceutical industry is to make drugs easily accessible in the local markets. Also, the demand for sophisticated and innovative medicines has increased as the common man lives the western lifestyle. The Indian pharmaceutical industry needs to make more investments in R & D and distribution. Quality wise India is still not up to the international standards. For India to become a top player in the global pharmaceutical business, the government of India needs to support foreign investments in pharmaceuticals and biotechnology. Also, biotechnology in India is yet to reach its true potential but it’s definitely on its way with the growing importance of vaccines ad bio-services.

However, with talented human resource, advanced technology, low-cost products and mergers & acquisitions with MNCs, the pharmaceutical business in India holds the promise of being one of the top pharmaceutical industries in the world.

Chris Shirley writes articles on pharmaceutical industry to explain the role of pharmaceutical business in pharma industry.

By Chris Shirley

Article Source: http://EzineArticles.com/?expert=Chris_Shirley

http://EzineArticles.com/?The-Growth-of-the-Indian-Pharmaceutical-Industry&id=4390954

Thus, with the business environment conducive for the Indian Pharma companies, we recommend a selective investment approach towards the sector, emphasizing on companies that have the capability to capitalize on patent expiries in the US, have a strong and stable core business, sound financials to bet on and rich pipeline of growth.

About GEPL:
GEPL is a stock trading company which offers online trading stocks equities, commodities, f&o, debt, insurance and mutual funds. Along with its online trading services, GEPL also offers wealth management, portfolio management and financial advisory services.

By Ruchi M

Article Source: http://EzineArticles.com/?expert=Ruchi_M

http://EzineArticles.com/?The-Indian-Pharma-Industry—A-Defensive-Bet&id=5125552

Medical supply sales careers are not a new thing. In fact these types of jobs have been present for a long time. The most common type of medical supply sales job is that of the medical representative.

A medical sales representative is employed by a pharmaceutical company and it is these sales reps’ job to call on physicians and pay them visits to give them free samples of the drugs that the pharmaceutical company carries. Medical sales representatives are employed by pharmaceutical companies as a means to deliver targeted marketing to physicians who have the power to prescribe these medications to their patients. This way, pharmaceutical companies can push the sales of their products through the doctors that prescribe them to the patients that need them.

This type of sales tactic is especially successful for marketing and pushing the sales of prescription drugs. This is because mass marketing of prescription drugs is not possible and the best way to push sales of these is by targeting the physicians that can choose to prescribe them to their patients.

Getting into this type of job is especially promising, lucrative and satisfying for those who have an inclination for sales. If you don’t have any sales experience or you’re not sure if a career in sales is for you, don’t despair. A medical supply sales career may still be for you.

Sales people possess excellent communications skills focused on the ability to persuade and convince others into a desired action. In the case of the medical representative of a pharmaceutical company, the sales person needs to convince the physician to choose their type of medication over the rest. To do this, the sales rep needs very good relationship building and management skills. Most medicines in the same category have the same attributes and efficacy so sometimes, it really all boils down to the skill of the medical rep to sell his products effectively.

Given this, particularly good medical sales reps are compensated very well through actual financial perks but also through fringe benefits like a good service car and vacation and leisure packages. This is why many people consider getting into this type of job and decide to stay and advance in their careers here.

These days though, sales careers in medicine are not only confined to sales reps from different pharmaceutical companies trying to sell different prescription and non-prescription drugs to physicians. Medical supply sales careers are more encompassing than that these days as different outfits need more and more individuals to join their dynamic workforce to help push the trial and sales of different medical supplies to different health care facilities.

Medical supply sales careers are now not only offered by pharmaceutical companies but by different medical and health care companies that have good products to sell through targeted sales tactics.

Article Source: http://www.articlesbase.com/careers-articles/learn-about-having-a-career-in-medical-supply-2011263.html

About the Author

Author: Fritz Poole

For tips on lip discoloration, pelvic cramps and other information, visit the Health And Nutrition Tips website.

Healthcare payers are also feeling the impact of the global economic downturn.
As a result, payers are introducing a number of cost-containment strategies as well as tougher regulatory measures

Aarkstore.com announce a new report through its vast collection of market research report :

Pharmaceutical Key Trends 2011 Overview

For some-more information, Great fully visit:

http://www.aarkstore.com/reports/Pharmaceutical-Key-Trends-2011-Overview-Key-strategic-trends-in-the-pharmaceutical-industry-136195.html

Features and benefits

* An overview of drivers of rising healthcare costs
* Review the impact of the global economic downturn on the healthcare and the pharmaceutical industry
* Assess the growing cost-containment and regulatory pressures facing pharma
* An overview of the impact of the patent expiries on pharma together with the industry’s responses

Highlights

Aging populations, the growing prevalence of chronic disease, greater use of expensive treatments, and expanding public healthcare coverage are stretching existing healthcare resources. As a result of rising unemployment, healthcare payers are also feeling the impact of the global economic downturn through reduced funding via taxation.
In response, payers are introducing a number of cost-containment strategies, such as reducing healthcare budgets and implementing pricing and reimbursement cuts, as well as bolstering generic uptake. These measures, together with the increasingly tough regulatory environment, all have a negative impact on the pharmaceutical industry.
Branded pharmaceutical companies are set to lose approximately $100bn in sales due to the patent cliff and the resultant generic erosion of branded sales during 2010–15 in the seven major markets, while the industry is also feeling the effects of the recent global economic downturn both directly and indirectly.

Your key questions answered

* Evaluate factors driving healthcare costs in the developed and emerging markets, and how the economic downturn has impacted the healthcare landscape
* Gain insight into the impact that the patent cliff as well as growing use of biosimilars will have on branded pharma sales out to 2015
* Review the growing cost-containment and regulatory measures facing pharma, as well as the industry’s response to grow profitability going forward

Table of Contents :
Executive Summary
Strategic scoping and focus
Key findings
DRIVERS OF RISING HEALTHCARE COSTS
Demographic trends in the major developed and emerging markets
Aging patient populations
Growing prevalence of chronic diseases
Greater use of expensive treatments – pharmaceutical expenditure is increasing in all markets
Expanding pubic healthcare coverage
IMPACT OF THE GLOBAL ECONOMIC DOWNTURN ON HEALTHCARE AND PHARMA
Impact of the economic downturn on both developed and emerging markets
Growing uninsured population – US patients are less able to cover the costs of healthcare, including pharmaceuticals
Government strategies to cut the budget deficit target healthcare and pharmaceutical expenditure
COST-CONTAINMENT AND REGULATORY PRESSURES
Government strategies to contain healthcare and pharma costs
Healthcare spending has slowed in several markets as governments bring in austerity measures
Pricing and reimbursement cuts were key elements included in austerity measures in many developed markets
Regulatory changes have a largely negative impact on pharma
Healthcare systems globally are converging toward a similar model
Driving generic uptake will create further savings
THE PATENT CLIFF
The patent cliff represents a major resistor to branded pharma growth
Branded pharma set to lose $82bn due to the patent cliff
Biosimilar uptake is set to accelerate
PHARMA’S STRATEGIC RESPONSES TO DRIVE PROFITABILITY

Article Source: http://www.articlesbase.com/medical-tourism-articles/pharmaceutical-key-trends-2011-overview-key-strategic-trends-in-the-pharmaceutical-market-analysis-report-4943116.html

About the Author

Author: aksdes0109

We specialize in providing online market business information on market research reports, books, magazines, conference booking at competitive prices, and strive to provide excellent and innovative service to our customers.

Roles and responsibilities

In order to endorse the deal of medicines a medical representative has to get in touch with the physicians, nursing homes, hospitals, druggists, etc. in specific locations to set up or introduce medical products of his company and then lead sales. The health care official is required to do arrangements for daily visits to doctors, nursing homes, hospitals, chemist shops, etc. in his specified areas.

The representative is obligatory to initiate to physicians and others medical professionals, to make sure that the medical products of his company are sold which indeed shows his merit. He is required to track up his visits to determine the views concerning the products of his company and encourage clients to prescribe his company’s products to consumers or patients.

The official is required to maintain proper record of receipt and distribution of samples which is open for inspection by his Area Manager. He offers credit facilities, commissions, etc: to the customers as authorized by his company. He books orders and forwards them to the controlling office for compliance.

He submits daily reports of his canvassing activities to the Area Manager and gives suggestions for improving sales. He is responsible for collection of payment. The medical official accepts introduction of existing or new product by the company and fully cooperate in making it a success. A Medical Representative who has a flair for marketing and can show extra-ordinary results can rise to the highest position of Marketing Manager.

Choose an expert

Though there are many ways to select or employ medical representatives however to keep it simple and easy the Multinational Pharmaceutical companies outsource specialized health care recruitment firms to recruit potential Medical Representatives at various locations across the world. Outsourcing expert recruitment consultants not only saves time and efforts but also helps the company to focus on their core business while they look after the crucial and time consuming employment process. There are various employment and human resource services offered by these employment firms which you may select as per your specific business requirement.

So, by which measure will you select a medical representative?

Article Source: http://www.articlesbase.com/dental-care-articles/how-to-select-a-medical-representative-4704036.html

About the Author
Author: Praveen

MME Medical Recruitment agency is a specialized division of MM Enterprises Manpower Consultants. We bring to you the best talent in Helath Care and Medicene industry with a hassle free search and appointment procedure. We provide both Locum Doctors and Permanet doctors for UK, Gulf, Australia and India.